Should You Buy Defensive Stocks British American Tobacco plc, GlaxoSmithKline plc & Centrica PLC?

Will Defensive Stocks British American Tobacco plc (LON:BATS), GlaxoSmithKline plc (LON:GSK) & Centrica PLC (LON:CNA) Outperform In 2016?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

World markets remain unstable despite the recent rally in equities . Investors looking to park capital in stocks that should perform ok in a prolonged bear market should be researching defensive plays. Historically defensive stocks have been in the consumer, utilities and healthcare sectors. The three stocks below are perfect defensive stocks that should hold up well in a downturn. 

Tobacco king

British American Tobacco (LSE: BATS) has been an outstanding performer since the year 2000, the share price has increased by a whopping 629% and the company has returned billions to shareholders in the form of dividends. The company manages to maintain margins of 30-36% and generate over £4bn in net profit each year.

Shareholders will see a substantial amount of this profit returned in a dividend of 154p a share (3.9%) which is covered 1.6 times by cash. The company is relatively cheap too — currently shares are trading on a P/E ratio of just over 17. This is lower than London’s other large tobacco stock Imperial Brands (LSE: IMB). 

British American Tobacco is a great stock to own in times like these because of the defensive nature of tobacco companies and the huge profit the company has consistently delivered for years. 

Pharma giant

GlaxoSmithKline (LSE: GSK) is an extremely popular defensive stock in the US and UK. The company operates in the healthcare sector and is expected to have revenues of over £25bn this year. Glaxo pays out a punchy 6% dividend and the shares still only trade on a P/E of 15, which is firmly in the bottom half of  its peer group.

The strong defensive qualities can be seen when looking at a 10 year chart for the stock — impressively the stock rose in during the 2008/2009 global financial crisis. This would suggest that if the world economy enters another recession then Glaxo shares would be a great place to have invested. 

The company has developed an exciting range of new drugs and treatments to help fill the revenue gap left by old treatments coming off patents. Although revenue is declining the company is keeping profits relatively steady, and the stock is definitely one to own in a downturn.  

UK utility

Utility stocks such as Centrica (LSE: CNE) are not something I would usually look at. However, in the current economic climate the sector may well outperform others by the end of the year. The headline attraction to Centrica is the 5.3% dividend yield but there could be a good turnaround story here.

After two years of losses the company is forecast to swing into a profit for 2016 and 2017 which could cause the shares to re-rate. The forecast P/E ratio for 2016 is 12.5 which is a good deal lower than its listed peers and that is something that I would expect to change. Centric has defensive qualities like the other stocks mentioned here but there is also considerable scope for capital growth. 

Centrica is reporting this week so that may give us some confirmation of the companies change in fortunes and the outlook going forward. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jack Dingwall has no position in any shares mentioned. The Motley Fool UK has recommended Centrica and GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

£20,000 in savings? Here’s how I’d aim to turn that into passive income of £903 a month

Our writer shares one approach to passive income investing, spotlighting a quality FTSE 100 stock he recently added to his…

Read more »

Investing Articles

Great dividend stocks! Here’s the forecast for Associated British Food shares to 2027

Associated British Foods' shares have dropped in value this year. Does this present a dip-buying opportunity for dividend investors to…

Read more »

Investing Articles

Should I sell my FTSE All-Share index fund and buy a S&P 500 tracker instead?

Harvey Jones is wondering whether now is a good time to invest more money in the S&P 500, after a…

Read more »

Investing Articles

Should I buy dirt-cheap BT shares after the recent pullback?

BT shares were on the up but now they're sliding again after the board trimmed full-year guidance. Now Harvey Jones…

Read more »

Investing Articles

Up 28%, can the easyJet share price keep rising?

The easyJet share price has gained altitude over one year but plunged over five. Is now an attractive time for…

Read more »

British Isles on nautical map
Investing Articles

Should I buy more BAE Systems shares at 1,350p?

BAE Systems shares have had a fantastic run since early 2022, yet still don't appear overvalued. Is it now time…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

7% yield and a cheap valuation! Is this one of the best shares to buy this month?

Christopher Ruane has been looking for cheap shares to buy. This one has a 7% dividend yield, so is it…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

Should I buy National Grid shares for the big dividend before it’s too late?

This year's price weakness has left National Grid shares on what looks like a tempting valuation. I hope it doesn't…

Read more »